Quipt Home Medical Corp. (QIPT)
NASDAQ: QIPT · Real-Time Price · USD
3.645
+0.005 (0.14%)
Mar 9, 2026, 2:35 PM EDT - Market open
Company Description
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States.
The company offers nebulizers; invasive ventilation; and sleep apnea and pap treatment, home ventilation, equipment solutions, daily and ambulatory aids, power mobility, respiratory equipment rental, oxygen therapy services.
It also provides solutions that supports patients dealing with heart and pulmonary disease, reduced mobility, obesity, and other chronic health conditions.
The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021.
Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
Quipt Home Medical Corp.
| Country | United States |
| Founded | 1993 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 1,500 |
| CEO | Gregory Crawford |
Contact Details
Address: 1019 Town Drive Wilder, Kentucky 41076 United States | |
| Phone | 859 878 2220 |
| Website | quipthomemedical.com |
Stock Details
| Ticker Symbol | QIPT |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001540013 |
| CUSIP Number | 74880P104 |
| ISIN Number | CA74880P1045 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Gregory John Crawford | Chairman, President and Chief Executive Officer |
| Hardik Mehta | Chief Financial Officer |
| Thomas William Roehrig | Chief Accounting Officer |
| William Todd Zehnder | Chief Strategy Officer and Investor Relations |
| Mark Alan Miles | Chief Compliance Officer |
| Cole Stevens | Vice President of Corporate Development |
| David Alan Bachelder | Executive Vice President of Operations |
| Patrick Dennis Gamble | Executive Vice President of Operations |
| Robert Grossman LLB | Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 6, 2026 | 8-K | Current Report |
| Mar 3, 2026 | 8-K | Current Report |
| Feb 10, 2026 | SCHEDULE 13G/A | Filing |
| Feb 9, 2026 | 10-Q | Quarterly Report |
| Feb 4, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Feb 4, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Feb 4, 2026 | DEFM14A | Filing |
| Jan 28, 2026 | 10-K/A | [Amend] Annual report |
| Jan 26, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jan 26, 2026 | 8-K | Current Report |